These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 6206405
1. Differential effects of Bay k 8644, a presumed calcium channel activator, on sinoatrial nodal and ventricular automaticity of the dog heart. Satoh K, Wada Y, Taira N. Naunyn Schmiedebergs Arch Pharmacol; 1984 Jun; 326(2):190-2. PubMed ID: 6206405 [Abstract] [Full Text] [Related]
2. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog. Wada Y, Satoh K, Taira N. Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147 [Abstract] [Full Text] [Related]
3. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues. Nakaya H, Hattori Y, Tohse N, Kanno M. Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192 [Abstract] [Full Text] [Related]
4. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations. Satoh K, Wada Y, Taira N. Arzneimittelforschung; 1986 Aug; 36(1):35-9. PubMed ID: 2937413 [Abstract] [Full Text] [Related]
5. New Ca2+ agonist (Bay K 8644) enhances and induces cardiac slow action potentials. Wahler GM, Sperelakis N. Am J Physiol; 1984 Aug; 247(2 Pt 2):H337-40. PubMed ID: 6205600 [Abstract] [Full Text] [Related]
12. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts. Orito K, Satoh K, Taira N. J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172 [Abstract] [Full Text] [Related]
13. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Schramm M, Thomas G, Towart R, Franckowiak G. Arzneimittelforschung; 1983 Aug; 33(9):1268-72. PubMed ID: 6196037 [Abstract] [Full Text] [Related]
14. Regulation of cardiac calcium channel current and contractile activity by the dihydropyridine Bay K 8644 is voltage-dependent. Sanguinetti MC, Kass RS. J Mol Cell Cardiol; 1984 Jul; 16(7):667-70. PubMed ID: 6206231 [Abstract] [Full Text] [Related]
15. Modulation of myocardial economy and efficiency in mammalian failing and non-failing myocardium by calcium channel activation and beta-adrenergic stimulation. Ruf T, Hebisch S, Gross R, Alpert N, Just H, Holubarsch C. Cardiovasc Res; 1996 Dec; 32(6):1047-55. PubMed ID: 9015407 [Abstract] [Full Text] [Related]
16. Comparative study of MDL 17043 and MDL 19205, new positive inotropic agents, by use of isolated, blood-perfused dog-heart preparations. Wada Y, Taira N. Heart Vessels; 1986 Dec; 2(1):29-35. PubMed ID: 2941407 [Abstract] [Full Text] [Related]
17. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart. Takahashi K, Taira N. Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072 [Abstract] [Full Text] [Related]
18. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart. Wada Y, Satoh K, Taira N. J Cardiovasc Pharmacol; 1985 Jul; 7(1):190-6. PubMed ID: 2580142 [Abstract] [Full Text] [Related]
19. Recovery of the slow action potential is hastened by the calcium slow channel agonist, Bay-K-8644. Sada H, Sada S, Sperelakis N. Eur J Pharmacol; 1986 Jan 14; 120(1):17-24. PubMed ID: 2419143 [Abstract] [Full Text] [Related]
20. Selective inhibition by E4080, a novel bradycardic agent, of positive chronotropic responses to norepinephrine in isolated dog hearts. Sawaki S, Furukawa Y, Inoue Y, Oguchi T, Chiba S. Eur J Pharmacol; 1993 Dec 07; 250(2):253-9. PubMed ID: 7509284 [Abstract] [Full Text] [Related] Page: [Next] [New Search]